Physician profile
Andrew M Duda
NPI 1124026075
$2,948.16
in general payments reported to CMS, 2019-2025
12 companies · $43.69 in 2025
The $43.69 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,812 · 2022: $913 · 2023: $87.50 · 2024: $91.97 · 2025: $43.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $2,550.00 | 2021-2022 | |
| Medical Device Business Services, INC. | $107.69 | 2021 | |
| Medtronic, INC. | $71.24 | 2023-2025 | Chameleon, Avalus |
| Abbott Laboratories | $50.09 | 2023-2025 | Diamondback Peripheral, Esprit |
| Acrotech Biopharma INC. | $34.66 | 2024 | Beleodaq |
| Integra Lifesciences Corporation | $26.20 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Getinge USA Sales, LLC | $24.11 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.77 | 2024 | Ultomiris |
| Sobi, INC | $18.20 | 2024 | |
| Terumo Medical Corporation | $15.31 | 2022 | |
| Livanova USA, INC. | $14.89 | 2022 | |
| W. L. Gore & Associates, INC. | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Duda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.